Abstract |
To determine whether a weight-adjusted high dose (2 mg/kg body weight over 3 h) rapid infusion of recombinant tissue-type plasminogen activator (rt-PA) was more efficacious than a weight-adjusted standard dose (1.25 mg/kg over 3 h) in achieving reperfusion in the setting of acute myocardial infarction, 175 patients were entered into a randomized multicenter trial. Eighty-four patients were entered into the high dose group, receiving 1.2 mg/kg (10% given as a bolus injection) over 1 h, followed by 0.8 mg/kg over the next 2 h. Ninety-one patients were given 0.75 mg/kg (10% given as a bolus injection) in 1 h, followed by 0.5 mg/kg administered over the next 2 h. The median dose in the group that received 2 mg/kg dose was 145 mg, compared with 100 mg in the group that received 1.25 mg/kg. The 90 min patency rate in the group that received 2 mg/kg was 84% compared with 70% in the group that received 1.25 mg/kg (p = 0.003). Sixty-four percent of the patients in each group underwent coronary angioplasty at the time of cardiac catheterization. The infarct-related artery patency rate at the end of catheterization was 91% in the group that received 2 mg/kg compared with 83% in the group that received 1.25 mg/kg (p = 0.08). Among patients with a patent infarct-related coronary artery after catheterization, the 6 month mortality rate in the group that received 2 mg/kg was 2.9% compared with 9.8% in the group that received 1.25 mg/kg (p = 0.15). The bleeding complication rate in the two groups was similar.(ABSTRACT TRUNCATED AT 250 WORDS)
|
Authors | R W Smalling, R Schumacher, D Morris, K Harder, F Fuentes, R P Valentine, L L Battey Jr, M Merhige, D E Pitts, H A Lieberman |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 15
Issue 5
Pg. 915-21
(Apr 1990)
ISSN: 0735-1097 [Print] United States |
PMID | 2107237
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Tissue Plasminogen Activator
|
Topics |
- Adult
- Aged
- Angioplasty, Balloon, Coronary
- Blood Coagulation
(drug effects)
- Cerebral Hemorrhage
(chemically induced, diagnostic imaging)
- Coronary Angiography
- Drug Administration Schedule
- Female
- Hemorrhage
(chemically induced)
- Humans
- Male
- Middle Aged
- Multicenter Studies as Topic
- Myocardial Infarction
(diagnostic imaging, drug therapy, mortality)
- Randomized Controlled Trials as Topic
- Recurrence
- Survival Rate
- Tissue Plasminogen Activator
(administration & dosage, adverse effects)
- Vascular Patency
(drug effects)
|